ABOLITION OF SEIZURE PROVOKING EFFECT OF SUMATRIPTAN BY FLUOXETINE IN PENTYLENETETRAZOL INDUCED SEIZURES IN RATS
Abstract
Â
 Objectives: The objective was to evaluate the seizure provoking effect of sumatriptan, and its abolition with fluoxetine in the pentylenetetrazol-induced seizures in rats.
Methods: 100 Sprague-Dawley rats of either sex were randomized into 10 groups with each group consisting 10 rats. The first group was taken as a control group which received distilled water. The second group and the third group were evaluated with standard anticonvulsant drug sodium valproate in the dose of 200 mg/kg and 250 mg/kg, respectively. The fourth group received sumatriptan in the dose 6 mg/kg. The fifth and sixth groups were evaluated for effect of fluoxetine in the dose of 6 mg/kg and 10 mg/kg, respectively. The seventh group was evaluated for the combined effect of sumatriptan 6 mg/kg and sodium valproate 200 mg/kg. The eighth group was administered fluoxetine 6 mg/kg and sodium valproate 200 mg/kg. The ninth group was evaluated for a combined effect of fluoxoetine 6 mg/kg and sumatriptan 6 mg/kg. The tenth group was evaluated for the combined effect of three drugs fluoxetine 6 mg/kg, sumatriptan 6 mg/kg, and sodium valproate 200 mg/kg. The rats were screened for the effect of various drugs by inducing seizures with pentylenetetrazol. The rats were analyzed for the parameters, i.e., the time for the onset of seizures, duration of tonic-clonic seizures, and for post seizure mortality up to 24 hrs.
Results: Sumatriptan reduced the seizure threshold in rats, and it has abolished the seizure protective effect of sodium valproate. Sodium valproate and fluoxetine had dose dependent seizure protective effect. Fluoxetine abolished the seizure threshold lowering effect of sumatriptan. Fluoxetine and sodium valproate combination produced additive seizure productive effect. The combination of sumatriptan, fluoxetine, and sodium valproate also raised the seizure threshold.
Conclusion: The seizure threshold lowering effect of sumatriptan was abolished by co-administration of fluoxetine.
Keywords: Fluoxetine, Sumatriptan, Pentylenetetrazol, Seizures.
Downloads
References
Peroutka SJ, McCarthy BG. Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sites. Eur J Pharmacol 1989;163(1):133-6.
Buterbaugh GG. Effect of drugs modifying central serotonergic function on the response of extensor and nonextensor rats to maximal electroshock. Life Sci 1978;23:2393-404.
Sparks DL, Buckholtz NS. Combined inhibition of serotonin uptake and oxidative deamination attenuates audiogenic seizures in DBA/2J mice. Pharmacol Biochem Behav 1985;23(5):753-7.
Trimble M, Anlezark G, Meldrum B. Seizure activity in photosensitive baboons following antidepressant drugs and the role of serotoninergic mechanisms. Psychopharmacology (Berl)1977;51(2):159-64.
Pasini A, Tortorella A, Gale K. The anticonvulsant action of fluoxetine in substantia nigra is dependent upon endogenous serotonin. Brain Res 1996;724(1):84-8.
Brunton LL, Lazo JS, Parker KL. Goodman and Gilman’s the Pharmacological Basis of Therapeutics. 11th ed. New York: McGraw Hill; 2006. p. 297-315.
7. Tripathi KD. Essentials of Medical Pharmacology. 7th ed. New Delhi: Jaypee Brothers Medical Publishers; 2013. p. 460-1.
Prendiville S, Gale K. Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats. Epilepsia 1993;34(2):381-4.
Browning RA, Wood AV, Merrill MA, Dailey JW, Jobe PC. Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors. Eur J Pharmacol 1997;336(1):1-6.
Dailey JW, Yan QS, Mishra PK, Burger RL, Jobe PC. Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. J Pharmacol Exp Ther 1992;260(2):533-40.
Vogel HG. Drug Discovery and Evaluation: Pharmacological Assays. 3rd ed. Germany: Springer; 2008. p. 662-709.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.